<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101649562</journal-id>
<journal-id journal-id-type="pubmed-jr-id">43473</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Pharmacol Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr Pharmacol Rep</journal-id>
<journal-title-group>
<journal-title>Current pharmacology reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2198-641X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30410853</article-id>
<article-id pub-id-type="pmc">6217844</article-id>
<article-id pub-id-type="doi">10.1007/s40495-018-0140-7</article-id>
<article-id pub-id-type="manuscript">NIHMS964601</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Control of CNS functions by RNA-binding proteins in neurological diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Yijing</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dong</surname>
<given-names>Fengping</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mao</surname>
<given-names>Yingwei</given-names>
</name>
<!--<email>yzm1@psu.edu</email>-->
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Biology, Pennsylvania State University, University Park, PA, 16802, USA</aff>
<author-notes>
<fn fn-type="equal" id="FN1">
<label>*</label>
<p id="P1">equal contribution</p>
</fn>
<fn fn-type="COI-statement" id="FN2">
<p id="P36">
<bold>Conflict of Interests</bold>
</p>
<p id="P37">The authors confirm that this article content has no conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>2</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>2</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2019</year>
</pub-date>
<volume>4</volume>
<issue>4</issue>
<fpage>301</fpage>
<lpage>313</lpage>
<!--elocation-id from pubmed: 10.1007/s40495-018-0140-7-->
<self-uri xlink:href="https://link.springer.com/article/10.1007/s40495-018-0140-7"></self-uri>
<abstract>
<sec id="S1">
<title>Purpose of Review</title>
<p id="P2">This review summarizes recent studies on the molecular mechanisms of RNA binding proteins (RBPs) that control neurological functions and pathogenesis in various neurodevelopmental and neurodegenerative diseases, including autism spectrum disorders, schizophrenia, Alzheimerâ€™s disease, amyotrophic lateral sclerosis, frontotemporal dementia, and spinocerebellar ataxia.</p>
</sec>
<sec id="S2">
<title>Recent Findings</title>
<p id="P3">RBPs are critical players in gene expression that regulate every step of posttranscriptional modifications. Recent genome-wide approaches revealed that many proteins associate with RNA, but do not contain any known RNA binding motifs. Additionally, many causal and risk genes of neurodevelopmental and neurodegenerative diseases are RBPs. Development of high-throughput sequencing methods has mapped out the fingerprints of RBPs on transcripts and provides unprecedented potential to discover new mechanisms of neurological diseases. Insights into how RBPs modulate neural development are important for designing effective therapies for numerous neurodevelopmental and neurodegenerative diseases.</p>
</sec>
<sec id="S3">
<title>Summary</title>
<p id="P4">RBPs have diverse mechanisms for modulating RNA processing and, thereby, controlling neurogenesis. Understanding the role of disease-associated RBPs in neurogenesis is vital for developing novel treatments for neurological diseases.</p>
</sec>
</abstract>
<kwd-group>
<kwd>RNA binding proteins</kwd>
<kwd>neurodevelopmental disorder</kwd>
<kwd>neurodegeneration</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>